SciSparc SPRC
NASDAQ SPRC
$0.38 +0.01 (+1.35%)
As of: Nov 11, 2026 · 9:45 AM EST

SciSparc (SPRC) Return on Assets [ROA] (2017 - 2019)

Updated

SciSparc's Return on Assets [ROA] was -139.84% in FY2025, down 70.43 percentage points from -69.41% in FY2024.

Analysis

SciSparc (SPRC) Return on Assets [ROA] (2017 - 2019) Analysis & Trends

From FY2016 onward, SciSparc has reported Return on Assets [ROA] for 10 years.

  • Return on Assets [ROA] has now declined for three consecutive years, with a five-year change of -330.15 percentage points (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual Return on Assets [ROA] in data going back to FY2016.
  • Per Business Quant data, Return on Assets [ROA] in earlier years was -69.41% in FY2024 (-15.41 pp), -54.00% in FY2023 (-79.27 pp), 25.26% in FY2022 (+118.06 pp) and -92.79% in FY2021 (-283.10 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 SciSparc 138,868.72 -6.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -445.01%
Mar 31, 2019 -248.72%
Jun 30, 2018 -41.91%
Mar 31, 2018 -41.71%
Dec 31, 2017 -49.50%
Sep 30, 2017 10.79%
Jun 30, 2017 15.15%
Mar 31, 2017 46.67%
API Access

SciSparc Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SPRC&period=max&api_key=YOUR_API_KEY